2-Methoxyestradiol and paclitaxel have similar effects on the cell cycle and induction of apoptosis in prostate cancer cells

This publication has 35 references indexed in Scilit:

• Mechanism of action of 2-methoxyestradiol: new developments
  Drug Resistance Updates, 2003
• Roles of p38- and c-jun NH2-terminal kinase-mediated pathways in 2-methoxyestradiol-induced p53 induction and apoptosis
  Carcinogenesis: Integrative Cancer Research, 2003
• 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF
  Cancer Cell, 2003
• Identification of a novel Bcl‐xL phosphorylation site regulating the sensitivity of taxol‐ or 2‐methoxyestradiol‐induced apoptosis
  FEBS Letters, 2003
• 2‐Methoxyestradiol, a Promising Anticancer Agent
  Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2003
• Mechanisms for 2‐methoxyestradiol‐induced apoptosis of prostate cancer cells
  FEBS Letters, 2002
• 2-Methoxyestradiol Induces G2/M Arrest and Apoptosis in Prostate Cancer
  Biochemical and Biophysical Research Communications, 2001
• 2‐methoxyestradiol blocks cell‐cycle progression at G₂/M phase and inhibits growth of human prostate cancer cells
  Molecular Carcinogenesis, 2001
• Paclitaxel-induced cell death
  Cancer, 2000
• 2-Methoxyestradiol: an Endogenous Antiangiogenic and Antiproliferative Drug Candidate
  Cancer and Metastasis Reviews, 2000